Cargando…

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic

Intravenous (IV) administration of antiviral monoclonal antibodies (mAbs) can be challenging, particularly during an ongoing epidemic, due to the considerable resources required for performing infusions. An ebolavirus therapeutic administered via intramuscular (IM) injection would reduce the burdens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuang, Erin, Cross, Robert W., McCavitt-Malvido, Maria, Abelson, Dafna M., Borisevich, Viktoriya, Stuart, Lauren, Agans, Krystle N., Mlakar, Neil, Marimuthu, Arumugapradeep, Deer, Daniel J., Shestowsky, William S., Kim, Do, Geisbert, Joan B., Zeitlin, Larry, Moyer, Crystal L., Roy, Chad J., Geisbert, Thomas W., Bornholdt, Zachary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228268/ https://www.ncbi.nlm.nih.gov/pubmed/35745509 http://dx.doi.org/10.3390/pathogens11060655

Ejemplares similares

Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
por: Woolsey, Courtney, et al.
Publicado: (2022)

Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Woolsey, Courtney, et al.
Publicado: (2021)

The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
por: Cross, Robert W., et al.
Publicado: (2016)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

Combination therapy protects macaques against advanced Marburg virus disease
por: Cross, Robert W., et al.
Publicado: (2021)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses
por: Daaboul, George G., et al.
Publicado: (2017)

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Cross, Robert W., et al.
Publicado: (2020)

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
por: Zeitlin, Larry, et al.
Publicado: (2021)

133 Structural basis for ebolavirus matrix assembly and budding; protein plasticity allows multiple functions
por: Bornholdt, Zachary, et al.
Publicado: (2014)

Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
por: Cross, Robert W., et al.
Publicado: (2020)

Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication
por: Olsen, Michelle E., et al.
Publicado: (2016)

Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus
por: Garamszegi, Sara, et al.
Publicado: (2014)

Ebolavirus Database: Gene and Protein Information Resource for Ebolaviruses
por: Swetha, Rayapadi G., et al.
Publicado: (2016)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W, et al.
Publicado: (2020)

Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
por: Cross, Robert W., et al.
Publicado: (2020)

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
por: Cross, Robert W., et al.
Publicado: (2021)

A Shared Structural Solution for Neutralizing Ebolaviruses
por: Dias, João M., et al.
Publicado: (2011)

An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
por: Geisbert, Joan B, et al.
Publicado: (2020)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
por: Cross, Robert W, et al.
Publicado: (2018)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)

A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
por: Foster, Stephanie L., et al.
Publicado: (2022)

Correction for Olsen et al., “Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication”
por: Olsen, Michelle E., et al.
Publicado: (2018)

Assembly and Budding of Ebolavirus
por: Noda, Takeshi, et al.
Publicado: (2006)

Ebolavirus comparative genomics
por: Jun, Se-Ran, et al.
Publicado: (2015)

Ebolavirus and Other Filoviruses
por: Leroy, E., et al.
Publicado: (2007)

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
por: Gilchuk, Pavlo, et al.
Publicado: (2018)

Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species
por: Hernandez, Humberto, et al.
Publicado: (2015)

Ebolavirus Evolution: Past and Present
por: de La Vega, Marc-Antoine, et al.
Publicado: (2015)

Virological diagnosis of Ebolavirus infection
por: Smith, D. W., et al.
Publicado: (2015)

Ebolavirus: Infection, Vaccination and Control
por: Ahad, Abdul, et al.
Publicado: (2022)

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge
por: Woolsey, Courtney, et al.
Publicado: (2022)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
por: Woolsey, Courtney, et al.
Publicado: (2023)

Natural history of nonhuman primates after conjunctival exposure to Ebola virus
por: Cross, Robert W., et al.
Publicado: (2023)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
por: Mire, Chad E., et al.
Publicado: (2016)

Structural Basis for Differential Neutralization of Ebolaviruses
por: Bale, Shridhar, et al.
Publicado: (2012)

Ebolavirus Replication and Tetherin/BST-2
por: Yasuda, Jiro
Publicado: (2012)

Discovery of an Ebolavirus-Like Filovirus in Europe
por: Negredo, Ana, et al.
Publicado: (2011)

Reston Ebolavirus Antibodies in Bats, the Philippines
por: Taniguchi, Satoshi, et al.
Publicado: (2011)

Discovery of an antibody for pan-ebolavirus therapy
por: Furuyama, Wakako, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fn0atge1bnejj6ambtqoqhvhqt